Mark Avagliano

Insider Reports History

Entity
Individual
Location
79 T.W. Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Avagliano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Business Officer Common Stock 0 $0 $2.51 Sep 18, 2024 Direct
G1 Therapeutics, Inc. Chief Business Officer Stock Option (right to buy) 0 Sep 18, 2024 Direct

Insider Reports Filed by Mark Avagliano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTHX G1 Therapeutics, Inc. Sep 18, 2024 5 $0 4 Sep 18, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. Jul 5, 2024 1 -$6.62K 4 Jul 8, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. May 13, 2024 1 -$39K 4 May 15, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. Mar 20, 2024 1 $0 4 Mar 22, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2024 5 -$12.6K 4 Jan 8, 2024 Chief Business Officer
GTHX G1 Therapeutics, Inc. May 10, 2023 1 $0 4 May 12, 2023 Chief Business Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2023 2 $0 4 Jan 5, 2023 Chief Business Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2022 3 -$15.3K 4 Jan 5, 2022 Chief Business Officer